Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
7.72
+0.02 (0.26%)
At close: Mar 5, 2026, 4:00 PM EST
7.76
+0.04 (0.56%)
After-hours: Mar 5, 2026, 7:59 PM EST
Intensity Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 20 | 27 | 117 | - | - | - | |
| Market Cap Growth | -36.20% | -77.37% | - | - | - | - | |
| Enterprise Value | 13 | 24 | 102 | - | - | - | |
| Last Close Price | 7.72 | 44.00 | 214.25 | - | - | - | |
| PB Ratio | 2.10 | 9.11 | 8.93 | - | - | - | |
| P/TBV Ratio | 2.71 | 9.11 | 8.93 | - | - | - | |
| Debt / Equity Ratio | 0.02 | 0.05 | 0.01 | -0.88 | 1.78 | 0.06 | |
| Net Debt / Equity Ratio | -0.96 | -0.84 | -1.11 | -0.62 | -1.67 | -1.04 | |
| Quick Ratio | 3.11 | 1.48 | 3.73 | 0.19 | 1.23 | 6.96 | |
| Current Ratio | 3.60 | 1.92 | 3.91 | 0.21 | 1.27 | 7.04 | |
| Return on Equity (ROE) | -234.70% | -202.34% | -261.36% | - | -161.84% | -75.07% | |
| Return on Assets (ROA) | -101.66% | -93.90% | -54.58% | -135.34% | -65.19% | -40.77% | |
| Return on Capital Employed (ROCE) | -164.70% | -547.70% | -62.40% | 149.20% | -535.90% | -70.70% | |
| Earnings Yield | -60.00% | -61.19% | -8.97% | - | - | - | |
| Buyback Yield / Dilution | -66.92% | -61.40% | -152.67% | - | -0.02% | -0.19% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.